Results 271 to 280 of about 256,813 (405)

Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Journal of Infectious Diseases, 2017
Yeon Joo Lee, Esther Arguello, R. Jenq, E. Littmann, Grace J Kim, Liza Miller, Lilan Ling, Cesar J. Figueroa, E. Robilotti, M. Perales, J. Barker, S. Giralt, M. V. D. van den Brink, E. Pamer, Y. Taur   +14 more
semanticscholar   +1 more source

Risk factors for hemorrhagic cystitis in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation. [PDF]

Front Pediatr
Dou HH, Luo JM, Zhao YJ, Wang JG, Qin YH.   +4 more
europepmc   +1 more source

Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation

, 2003
Andrew J. Ullmann, Georg Heß, Karin Kolbe, Anne Friedrich-Freksa, Ralf G. Meyer, Harald Gschaidmeier, Christoph Huber, Thomas Fischer   +7 more
openalex   +2 more sources

Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up [PDF]

, 2004
Tohru Nakagawa, Masahiro Kami, Akiko Hori, Sung Won Kim, Naoko Murashige, Tamae Hamaki, Yukiko Kishi, Hiroyuki Fujimoto, Naoki Matsuoka, Eijiro Okajima, Motokiyo Komiyama, Ken-ichi Tobisu, Toshio Wakayama, Naokuni Uike, Kinuko Tajima, Atsushi Makimoto, Shinichiro Mori, Ryuji Tanosaki, Yoichi Takaue, Tadao Kakizoe   +19 more
openalex   +1 more source

Effect of NPM1 Mutation Subtype and Co‐Mutation Patterns on the Outcomes of Acute Myeloid Leukemia

European Journal of Haematology, EarlyView.
ABSTRACT Introduction NPM1 mutated AML without FLT3‐ITD is considered “favorable” per the recent ELN 2022 criteria. However, our center has been challenged with treatment‐refractory patients, prompting a search for additional prognostic factors. Methods We reviewed records of NPM1 AML patients from 2015 to 2024.
Kittika Poonsombudlert, Ratdanai Yodsuwan, Sarah Mott, Kathryn Crawford, Sarah Hornberg, Anthony N. Snow, Grerk Sutamtewagul, Margarida Magalhaes‐Silverman, Prajwal Dhakal   +8 more
wiley   +1 more source

Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis. [PDF]

Nat Commun
Schäfersküpper M, Simon A, Yorgan TA, von Brackel FN, Delsmann MM, Baranowsky A, Gagelmann N, Ayuk F, Schinke T, Amling M, Kröger N, Rolvien T.   +11 more
europepmc   +1 more source

7Risks and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation: The intensity of the conditioning regimen outweighs the effect of acute graft-versus-host disease

, 2003
Tetsuya Fukuda, R C Hackman, K.A. Guthrie, R.A. Carter, B. Sandmaier, Chris Davis, Philippe Martin, R Storb, David K. Madtes   +8 more
openalex   +1 more source

An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.

Journal of Infection and Chemotherapy, 2016
U. Şahin, S. Toprak, Pinar Ataca Atilla, Erden Atilla, T. Demirer   +4 more
semanticscholar   +1 more source

Allogeneic Haematopoietic Stem Cell Transplantation Using Reduced‐Intensity Fludarabine, Busulfan and Anti‐T‐Lymphocyte Globulin With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy

European Journal of Haematology, EarlyView.
ABSTRACT Fludarabine, busulfan, and anti‐T‐lymphocyte globulin (FLUBU3+ATLG) reduced‐intensity conditioning is an established preparative regimen for allogeneic haematopoietic stem cell transplantation in older patients with myeloid malignancy. We examined its modern‐day performance in 175 sequentially treated patients on our national programme ...
Chris Armstrong, Eibhlin Conneally, Catherine Flynn, Paul Browne, Mairead Ni Chonghaile, Carmel Ann Galligan, Hayley Foy‐Stones, Nicola Gardiner, Greg Lee, Nina Orfali   +9 more
wiley   +1 more source

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-center experience and assessment of quality of life. [PDF]

Ital J Pediatr
Zhang W, Huang Y, Su X, Zhao X, Sheng H, Liang C, Jiang M, Zeng C, Cai Y, Lin Y, Shao Y, Liu S, Jiang H, Liu L.   +13 more
europepmc   +1 more source